Jean Van Rampelbergh

Company: Imcyse

Job title: Chief Clinical Development Officer

Seminars:

Evaluating Tolerance Biomarkers of Efficacy & Patient Selection to Hone Strategies from Bench-to-Bedside 11:45 am

Highlighting the current state of play in antigen-specific tolerance biomarkers to illuminate the knowledge gaps to be filled Evaluating translatable and feasible biomarkers from preclinical to clinical development and phase I to phase II studiesRead more

day: Conference Day One